Dellai Fabiana, Pagotto Alberto, Sbrana Francesco, Ripoli Andrea, Danieli Giacomo, Colombo Alberto, D'Elia Denise, Geminiani Monica, Giuliano Simone, Sartor Assunta, Tascini Carlo
Department of Medicine (DMED), University of Udine, 33100 Udine, Italy.
Infectious Diseases Division, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.
J Fungi (Basel). 2025 May 21;11(5):400. doi: 10.3390/jof11050400.
Invasive candidiasis represents a major global health concern, with incidence and mortality rates expected to rise due to medical advancements and unavoidable risk factors. This retrospective, multicentric study was conducted in eight hospitals in a northeastern Italian region, enrolling adult patients diagnosed with candidemia from 1 January 2018 to 31 December 2022. Epidemiological trends and clinical characteristics were analyzed and compared to those from a prior regional study (2009-2011), allowing a fourteen-year comparative evaluation. A shift in species distribution was observed, with a decline in (from 65.7% to 57.8%) and a rise in non- species, particularly the complex (from 16.1% to 18.2%). Guideline adherence was assessed applying the EQUAL score; scores ≥ than 11.5 were independently associated with improved in-hospital survival (HR 3.51, < 0.001). Among individual score components, empiric echinocandin therapy and central venous catheter removal correlated with better outcomes. Centers with routine infectious disease (ID) consultations showed higher survival and adherence, reinforcing the value of specialist involvement. These findings support local epidemiological and management practice surveillance program adoption to address context-specific gaps, promote the adoption of best practices in BSI management-as expanded ID specialist consultations and education programs-and, ultimately, reduce candidemia-related mortality rates.
侵袭性念珠菌病是一个重大的全球健康问题,由于医学进步和不可避免的风险因素,其发病率和死亡率预计将会上升。这项回顾性多中心研究在意大利东北部一个地区的八家医院开展,纳入了2018年1月1日至2022年12月31日期间被诊断为念珠菌血症的成年患者。分析了流行病学趋势和临床特征,并与之前一项地区性研究(2009 - 2011年)的结果进行比较,从而进行了为期十四年的对比评估。观察到菌种分布发生了变化,白色念珠菌(从65.7%降至57.8%)有所减少,而非白色念珠菌,尤其是光滑念珠菌复合体(从16.1%升至18.2%)有所增加。应用EQUAL评分评估指南依从性;评分≥11.5分与住院生存率提高独立相关(风险比3.51,P<0.001)。在各个评分组成部分中,经验性棘白菌素治疗和拔除中心静脉导管与更好的预后相关。进行常规传染病会诊的中心显示出更高的生存率和依从性,这强化了专科医生参与的价值。这些发现支持采用当地流行病学和管理实践监测项目,以弥补特定背景下的差距,促进在念珠菌血症管理中采用最佳实践——如扩大传染病专科医生会诊和教育项目——并最终降低念珠菌血症相关死亡率。